Apaluda is Apalutamide, an androgen receptor pathway inhibitor. It is indicated for non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer and works by blocking androgen receptor signaling that supports prostate cancer progression.
| Product Name | Apaluda |
| Generic Name | Aprepitant |
| Formulation | Tablet |
| Available Pack Size | 3X10's |
| Available Strength | 60MG |